Mendelian provides early disease identification services for healthcare providers, focusing on rare diseases.

Mendelian

At Mendelian, our mission is to make rare diseases our priority. We have an amazing team who have built software, which enables doctors to help patients earlier, by finding the undiagnosed.

Did you know that rare diseases are not actually rare? More rare diseases are life-threatening condition that are collectively common. In fact, 1 in 17 of us will be affected by a rare disease in our lifetime. This is comparable to common diseases such as diabetes and asthma.

Rare disease symptoms often develop gradually and in different organ systems. This means patients present to different doctors for seemingly independent reasons making these diseases difficult to diagnose.

On average, rare disease patients experience 3 misdiagnoses, visit 5 different doctors and wait over 4 years before receiving a diagnosis in the UK. In the past decade, undiagnosed rare diseases have cost the NHS in excess of £3.4 billion. 

Innovate UK

NHS England

Google for Startups

Pitch@Palace

Mendelian  is excited to part of Health Innovation Oxford & Thames Valley “Power of Digital Health Partnerships” event today. To hear more about our great work with our NHS partners come and talk to us at our stand!

#DigitalHealthOx #raredisease #rarediseases #diagnosticodyssey

🚨 Exciting News! The rare disease community just submitted a sign-on letter to Congress, with 100+ patient orgs and advocates touting the establishment of an FDA Rare Disease Center of Excellence in the 2025 approps bill. 

This center aims to streamline the regulatory process for rare disease therapies, bringing hope to millions affected by rare diseases. 🧬💪

Read the full letter and learn more about this initiative here: https://bit.ly/RDCOE

#RareDisease #Advocacy #Healthcare #FDA #Congress #budget

Our team have authored a few great articles this year already:

⋅ Lost in the System: The Labyrinth of Rare Disease Diagnosis - EMJ - https://lnkd.in/ge9Bimuy - Peter Fish

⋅ The diagnostic odyssey in children and adolescents with X-linked hypophosphataemia: population-based, case-control study - Journal of Clinical Endocrinology & Metabolism - https://lnkd.in/g4Vib3T2 - Nadine Sawoky - Kyowa Kirin International plc. #xlh

⋅Identifying patients with undiagnosed small intestinal neuroendocrine tumours in primary care using statistical and machine learning: model development and validation study - British Journal of Cancer - https://lnkd.in/gUA6XTjx - Innovate UK #neuroendocrinetumours #NETs

⋅ A Machine Learning Algorithm for the Detection of Paroxysmal Nocturnal Haemoglobinuria (PNH) in UK Primary Care Electronic Health Records (preprint) - BMC Primary Care - https://lnkd.in/gAYKRV7D #pnh

#raredisease #rarediseases #diagnosticodyssey

Deborah Richards' piece in the Guardian Rare Disease supplement underscores the importance of leveraging technology and working collaboratively to create the environment for widespread change.

We are proud to collaborate with Alexion Pharmaceuticals, Inc. to help drive earlier diagnosis of #rarediseases through AI-powered technology.

In the UK alone, every day, 9 children are born with a rare, treatable genetic condition. 

In a world-leading research project, Genomics England will be testing 100,000 new born babies for 223 different #rarediseases. Such a valuable step for the future of healthcare!

Thank you for the support Optimum Patient Care and the vital service OPCRD provides!

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 3, 2024 11:43 PM	790d7d43
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Sep 3, 2024 11:45 PM	8086b8d7
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	13126815
crunchbase profile	general
li profile	general	Sep 3, 2024 11:43 PM	a20696b1
translate crunchbase fundingrounds	general
peers	general	Sep 3, 2024 11:43 PM	19066a50
news basic	general	Sep 3, 2024 11:43 PM	0ff731ae
bundesanzeiger	filings
financials download nd	financials
private financials	financials

CO:MENDELIAN

Mendelian